LD-2 disclosure · 1st Quarter - Termination Amendment (No Activity)
PERVASIS THERAPEUTICS
via K&L GATES, LLP
Coverage · No income or expenses were reported on this filing.
Client
- Description
- Development of biologically active cell-based therapeutics to treat serious illnesses.
- Location
- Massachusetts · United States of America
Registrant
- Firm
- K&L GATES, LLP
- Description
- Law firm
- Location
- Washington, District of Columbia, United States of America